Abstract

Lowe Syndrome is a developmental disorder characterized by eye, kidney, and neurological pathologies, and is caused by mutations in the phosphatidylinositol-5-phosphatase OCRL. OCRL plays diverse roles in endocytic and endolysosomal trafficking, cytokinesis, and ciliogenesis, but it is unclear which of these cellular functions underlie specific patient symptoms. Here, we show that mutation of Drosophila OCRL causes cell-autonomous activation of hemocytes, which are macrophage-like cells of the innate immune system. Among many cell biological defects that we identified in docrl mutant hemocytes, we pinpointed the cause of innate immune cell activation to reduced Rab11-dependent recycling traffic and concomitantly increased Rab7-dependent late endosome traffic. Loss of docrl amplifies multiple immune-relevant signals, including Toll, Jun kinase, and STAT, and leads to Rab11-sensitive mis-sorting and excessive secretion of the Toll ligand Spåtzle. Thus, docrl regulation of endosomal traffic maintains hemocytes in a poised, but quiescent state, suggesting mechanisms by which endosomal misregulation of signaling may contribute to symptoms of Lowe syndrome.

Highlights

  • Lowe syndrome is an X-linked disorder caused by mutations in the phosphoinositide-5-phosphatase OCRL (Oculocerebrorenal Syndrome of Lowe)

  • We found that in fruit flies, loss of OCRL caused transport defects at specific internal compartments in innate immune cells, resulting in amplification of multiple critical inflammatory signals

  • Similar inflammatory signals have been implicated in forms of epilepsy, which is a primary symptom in Lowe syndrome patients

Read more

Summary

Introduction

Lowe syndrome is an X-linked disorder caused by mutations in the phosphoinositide-5-phosphatase OCRL (Oculocerebrorenal Syndrome of Lowe). OCRL localizes to multiple membrane compartments and is involved in a range of cell biological processes, including clathrin-mediated endocytosis [4,5,6], intracellular trafficking [7,8,9,10], actin cytoskeleton regulation [6, 11, 12], ciliogenesis [13], and cytokinesis [11, 14]. It remains unclear precisely how these diverse cellular requirements contribute to tissue and organ level pathology in Lowe Syndrome patients. Drosophila expresses only a single homolog of OCRL, CG3573/dOCRL [14], and may be a useful model for understanding the functions of OCRL in complex tissues in vivo. dOCRL is required for cytokinesis in cultured S2 cells [14], but its functions have not yet been examined in vivo

Methods
Findings
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call